Business Context and Reporting Period
This Form 8-K was filed by Aspen Aerogels, Inc. on December 11, 2020, reporting an event that occurred on December 10, 2020. The filing addresses a specific amendment to executive compensation arrangements for the Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance and compensation event rather than financial performance.
Material Changes
The Board of Directors approved an amendment to a non-qualified stock option granted to CEO Donald R. Young on December 10, 2015. Specifically, the "SEIG Performance Option" covering 116,279 shares had a performance period originally set to end on December 10, 2020. The amendment extended this performance period to end on December 18, 2020. The vesting condition remains that the 30-day volume weighted average price (VWAP) of the Company's common stock must be at least $8.96 for at least 60 consecutive trading days during the performance period.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies beyond the specific terms of the option amendment.
Key Facts for Investor Verification
- CEO Donald R. Young's performance option vesting period was extended by 8 days to December 18, 2020.
- The option covers 116,279 shares with a price target of $8.96 VWAP for 60 consecutive trading days.
- The filing does not disclose whether the price target was met or if the option vested.
- No financial results or operational updates are included in this specific report.